Objectif
The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative. It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration. In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular plaques mainly composed of Aβ are a hallmark of post-mortem brains. These premises strongly suggest brain Aβ as a possible target for therapy and diagnosis of AD. In addition, it is known that brain and blood Aβ pools are in equilibrium via the blood-brain-barrier (BBB). Accordingly, it has been reported that removal of blood Aβ may withdraw the excess of brain Aβ by a “sink” effect. Thus, blood Aβ is another potential target. The aim of this project is to utilize nanoparticles (NPs) specifically engineered for targeting brain Aβ, for the combined diagnosis and therapy (theranostics) of AD. NPs (liposomes, solid lipid NPs, polymeric-NPs) will be multiple-functionalized with: i) a large arsenal of molecules (specific lipids, antiamyloidogenic drugs, polyphenols, heteroaromatic compounds, unnatural peptides and peptidomimetics, antibodies) interacting with Aβ in all aggregation forms, ii) PET or MRI contrast agents detecting such interaction, iii) molecules stimulating BBB crossing via the transcytotic route. Several artificial and cellular models will be used to fine-tune such features and to improve NPs biocompatibility, non-immunogenicity, non-toxicity and physical stability. Eventually, absorption, distribution, metabolism and excretion will be studied using animal models of AD. Different routes (i.v. oral, nasal) and protocols (two-step, NPs cocktails, aerosols) of administration will be utilized to boost NPs brain delivery. The prediction is that NPs will detect, disaggregate and remove Aβ brain deposits. In any case, NPs will interact with blood Aβ, withdrawing the excess of brain peptide by a “sink” effect.
Champ scientifique
Mots‑clés
Programme(s)
Appel à propositions
FP7-NMP-2007-LARGE-1
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
20126 MILANO
Italie
Voir sur la carte
Participants (18)
91405 ORSAY CEDEX
Voir sur la carte
845 Bratislava
Voir sur la carte
17177 Stockholm
Voir sur la carte
1105AZ Amsterdam
Voir sur la carte
2100 Goedoello
Voir sur la carte
20014 Turku
Voir sur la carte
10144 Torino
Voir sur la carte
265 04 Rio Patras
Voir sur la carte
2000 Antwerpen
Voir sur la carte
48940 Leioa
Voir sur la carte
LA1 4YW Lancaster
Voir sur la carte
20156 Milano
Voir sur la carte
2825 182 Caparica
Voir sur la carte
75252 PARIS
Voir sur la carte
93420 VILLEPINTE
Voir sur la carte
48008 BILBAO
Voir sur la carte
1165 Kobenhavn
Voir sur la carte
41013 Sevilla
Voir sur la carte